-
-
-
[1] LIU H W, KWONG Y L, BOURKE C, et al.High incidence of thrombophilia detected in Chinese patients with venous thrombosis[J].Thromb Haemost, 1994, 71:416-419.
[2] SHEN M C, LIN J S, TSAY W.High prevalence of antithromb III, protein C and protein S deficiency, but no factor V Leiden mutation in venous thrombophilic Chinese patients in Taiwan[J].Thromb Res, 1997, 87:377-385.
[3] 白春梅, 潘家绮, 范连凯, 等.静脉血栓患者抗凝蛋白缺陷研究[J].中华内科杂志, 2000, 39(11):746-748.
[4] 马艳, 张庆华.新疆维吾尔族正常人群抗活化的蛋白C发生率的调查[J].中华血液学杂志, 1996, 17(9):468-468.
[5] LIJFERING W M, BROUWER J L, VEEGER N J, et al.Selective testing for thrombophilia in patients with first venous thrombosis:results from a retrospective family cohort study on absolute thrombotic risk for currently known thrombophilic defects in 2479 relatives[J].Blood, 2009, 113:5314-5322.
[6] MIYAKIS S, LOCKSHIN M D, ATSUMI T, et al.International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)[J].J Thromb Haemost, 2006, 4:295-306.
[7] KEELING D, MACKIE I, MOORE G W, et al.Guidelines on the investigation and management of antiphospholipid syndrome[J].Br J Haematol, 2012, 157:47-58.
[8] SMALBERG J H, KRUIP M J, JANSSEN H L, et al.Hypercoagulability and hypofibrinolysis and risk of deep vein thrombosis and splanchnic vein thrombosis:similarities and differences[J].Arterioscler Thromb Vasc Biol, 2011, 31:485-493.
[9] DENTALI F, SQUIZZATO A, BRIVIO L, et al.JAK2V617F mutation for the early diagnosis of Ph-myeloproliferative neoplasms in patients with venous thromboembolism:a meta-analysis[J].Blood, 2009, 113:5617-5623.
-
计量
- 文章访问数: 44
- PDF下载数: 1007
- 施引文献: 0